The roles of adipokines, proinflammatory cytokines, and adipose tissue macrophages in obesity-associated insulin resistance in modest obesity and early metabolic dysfunction

PLoS ONE

Volumn 11, Issue 4, 2016, Pages

  Kang, Yea Eun ^a   Kim, Ji Min ^a   Joung, Kyong Hye ^a   Lee, Ju Hee ^a   You, Bo Ram ^a   Choi, Min Jeong ^a   Ryu, Min Jeong ^a   Ko, Young Bok ^b   Lee, Min A ^b   Lee, Junguee ^c   Ku, Bon Jeong ^a,b   Shong, Minho ^a,b   Lee, Ki Hwan ^b   Kim, Hyun Jin ^a  

^a Chungnam National University College of Medicine   (South Korea)

^b Chungnam National University   (South Korea)

^c Daejeon St Mary's Hospital   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPOCYTOKINE; ADIPONECTIN; LEPTIN; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; TUMOR NECROSIS FACTOR ALPHA; AUTACOID; CYTOKINE;

ADULT; ARTICLE; BODY MASS; CELL INFILTRATION; CONTROLLED STUDY; DISEASE ASSOCIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INSULIN RESISTANCE; INTRAABDOMINAL FAT; MACROPHAGE; MAJOR CLINICAL STUDY; METABOLIC DISORDER; OBESITY; PATHOPHYSIOLOGY; PHENOTYPE; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; ADIPOSE TISSUE; CASE CONTROL STUDY; CYTOLOGY; METABOLISM; MIDDLE AGED; PHYSIOLOGY;

ADIPOKINES; ADIPOSE TISSUE; ADULT; CASE-CONTROL STUDIES; CYTOKINES; FEMALE; HUMANS; INFLAMMATION MEDIATORS; INSULIN RESISTANCE; MACROPHAGES; MIDDLE AGED; OBESITY;

EID: 84964666658     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0154003     Document Type: Article

References (50)

1. Greenberg AS, Obin MS. Obesity and the role of adipose tissue in inflammation and metabolism. The American journal of clinical nutrition. 2006; 83(2):461S-5S. PMID: 16470013
2. Noto H, Goto A, Tsujimoto T, Osame K, Noda M. Latest insights into the risk of cancer in diabetes. Journal of diabetes investigation. 2013; 4(3):225-32. doi: 10.1111/jdi.12068 PMID: 24843658
3. Osborn O, Olefsky JM. The cellular and signaling networks linking the immune system and metabolism in disease. Nature medicine. 2012; 18(3):363-74. doi: 10.1038/nm.2627 PMID: 22395709
4. Lim S. Ectopic fat assessment focusing on cardiometabolic and renal risk. Endocrinology and Metabolism. 2014; 29(1):1-4. doi: 10.3803/EnM.2014.29.1.1 PMID: 24741447
5. Matsuzawa Y, Funahashi T, Nakamura T. Molecular Mechanism of Metabolic Syndrome X: Contribution of Adipocytokines. Adipocyte-derived Bioactive Substances. Annals of the New York Academy of Sciences. 1999; 892(1):146-54.
6. Spiegelman BM, Flier JS. Obesity and the regulation of energy balance. Cell. 2001; 104(4):531-43. PMID: 11239410
7. Kahn BB, Flier JS. Obesity and insulin resistance. Journal of clinical investigation. 2000; 106(4):473. PMID: 10953022
8. Weisberg SP, McCann D, Desai M, Rosenbaum M, Leibel RL, Ferrante AW Jr Obesity is associated with macrophage accumulation in adipose tissue. Journal of clinical investigation. 2003; 112(12):1796. PMID: 14679176
9. Cancello R, Henegar C, Viguerie N, Taleb S, Poitou C, Rouault C, et al. Reduction of macrophage infiltration and chemoattractant gene expression changes in white adipose tissue of morbidly obese subjects after surgery-induced weight loss. Diabetes. 2005; 54(8):2277-86. PMID: 16046292
10. Aouadi M, Tencerova M, Vangala P, Yawe JC, Nicoloro SM, Amano SU, et al. Gene silencing in adipose tissue macrophages regulates whole-body metabolism in obese mice. Proceedings of the National Academy of Sciences. 2013; 110(20):8278-83.
11. Olefsky JM, Glass CK. Macrophages, inflammation, and insulin resistance. Annual review of physiology. 2010; 72:219-46. doi: 10.1146/annurev-physiol-021909-135846 PMID: 20148674
12. Xu H, Barnes GT, Yang Q, Tan G, Yang D, Chou CJ, et al. Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. Journal of Clinical Investigation. 2003; 112 (12):1821. PMID: 14679177
13. Oguri S, Motegi K, Iwakura Y, Endo Y. Primary role of interleukin-1α and interleukin-1β in lipopolysaccharide-induced hypoglycemia in mice. Clinical and diagnostic laboratory immunology. 2002; 9 (6):1307-12. PMID: 12414765
14. Ichimura A, Hirasawa A, Poulain-Godefroy O, Bonnefond A, Hara T, Yengo L, et al. Dysfunction of lipid sensor GPR120 leads to obesity in both mouse and human. Nature. 2012; 483(7389):350-4. doi: 10.1038/nature10798 PMID: 22343897
15. Weisberg SP, Hunter D, Huber R, Lemieux J, Slaymaker S, Vaddi K, et al. CCR2 modulates inflammatory and metabolic effects of high-fat feeding. Journal of Clinical Investigation. 2006; 116(1):115. PMID: 16341265
16. Sakai S, Iizuka N, Fujiwara M, Miyoshi M, Aoyama M, Maeshige N, et al. Mild obesity reduces survival and adiponectin sensitivity in endotoxemic rats. journal of surgical research. 2013; 185(1):353-63. doi: 10.1016/j.jss.2013.06.002 PMID: 23838384
17. D'souza AM, Asadi A, Johnson JD, Covey SD, Kieffer TJ. Leptin deficiency in rats results in hyperinsulinemia and impaired glucose homeostasis. Endocrinology. 2014; 155(4):1268-79. doi: 10.1210/en.2013-1523 PMID: 24467741
18. Kanazawa M, Yoshiike N, Osaka T, Numba Y, Zimmet P, Inoue S. Criteria and classification of obesity in Japan and Asia-Oceania. Asia Pacific journal of clinical nutrition. 2002; 11(s8):S732-S7.
19. Association AD Diagnosis and classification of diabetes mellitus. Diabetes Care. 2014; 37(Supplement 1):S81-S90.
20. Hotta K, Funahashi T, Arita Y, Takahashi M, Matsuda M, Okamoto Y, et al. Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients. Arteriosclerosis, thrombosis, and vascular biology. 2000; 20(6):1595-9. PMID: 10845877
21. Staiger H, Tschritter O, Machann J, Thamer C, Fritsche A, Maerker E, et al. Relationship of serum adiponectin and leptin concentrations with body fat distribution in humans. Obesity research. 2003; 11 (3):368-76. PMID: 12634431
22. Makki K, Froguel P, Wolowczuk I. Adipose tissue in obesity-related inflammation and insulin resistance: cells, cytokines, and chemokines. ISRN inflammation. 2013; 2013.
23. Hu E, Liang P, Spiegelman BM. AdipoQ is a novel adipose-specific gene dysregulated in obesity. Journal of Biological Chemistry. 1996; 271(18):10697-703. PMID: 8631877
24. Klöting N, Fasshauer M, Dietrich A, Kovacs P, Schön MR, Kern M, et al. Insulin-sensitive obesity. American Journal of Physiology-Endocrinology and Metabolism. 2010; 299(3):E506-E15. doi: 10.1152/ajpendo.00586.2009 PMID: 20570822
25. Engeli S, Feldpausch M, Gorzelniak K, Hartwig F, Heintze U, Janke J, et al. Association between adiponectin and mediators of inflammation in obese women. Diabetes. 2003; 52(4):942-7. PMID: 12663465
26. Petersen KF, Oral EA, Dufour S, Befroy D, Ariyan C, Yu C, et al. Leptin reverses insulin resistance and hepatic steatosis in patients with severe lipodystrophy. Journal of Clinical Investigation. 2002; 109 (10):1345-50. PMID: 12021250
27. Segal KR, Landt M, Klein S. Relationship between insulin sensitivity and plasma leptin concentration in lean and obese men. Diabetes. 1996;45(7):988-91. PMID: 8666154
28. McArdle MA, Finucane OM, Connaughton RM, McMorrow AM, Roche HM. Mechanisms of obesity-induced inflammation and insulin resistance: insights into the emerging role of nutritional strategies. Frontiers in endocrinology. 2013; 4.
29. Guilherme A, Virbasius JV, Puri V, Czech MP. Adipocyte dysfunctions linking obesity to insulin resistance and type 2 diabetes. Nature reviews Molecular cell biology. 2008; 9(5):367-77. doi: 10.1038/nrm2391 PMID: 18401346
30. Cancello R, Tordjman J, Poitou C, Guilhem G, Bouillot JL, Hugol D, et al. Increased infiltration of macrophages in omental adipose tissue is associated with marked hepatic lesions in morbid human obesity. Diabetes. 2006; 55(6):1554-61. PMID: 16731817
31. Wentworth JM, Naselli G, Brown WA, Doyle L, Phipson B, Smyth GK, et al. Pro-inflammatory CD11c+ CD206+ adipose tissue macrophages are associated with insulin resistance in human obesity. Diabetes. 2010; 59(7):1648-56. doi: 10.2337/db09-0287 PMID: 20357360
32. Stanley TL, Zanni MV, Johnsen S, Rasheed S, Makimura H, Lee H, et al. TNF-α antagonism with etanercept decreases glucose and increases the proportion of high molecular weight adiponectin in obese subjects with features of the metabolic syndrome. The Journal of Clinical Endocrinology & Metabolism. 2011; 96(1):E146-E50.
33. Hotamisligil GS, Arner P, Caro JF, Atkinson RL, Spiegelman BM. Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance. Journal of Clinical Investigation. 1995; 95(5):2409. PMID: 7738205
34. Hotamisligil GS, Shargill NS, Spiegelman BM. Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science. 1993; 259(5091):87-91. PMID: 7678183
35. Catalán V, Gómez-Ambrosi J, Ramirez B, Rotellar F, Pastor C, Silva C, et al. Proinflammatory cytokines in obesity: impact of type 2 diabetes mellitus and gastric bypass. Obesity surgery. 2007; 17 (11):1464-74. PMID: 18219773
36. Christiansen T, Richelsen B, Bruun J. Monocyte chemoattractant protein-1 is produced in isolated adipocytes, associated with adiposity and reduced after weight loss in morbid obese subjects. Internationaljournal of obesity. 2005; 29(1):146-50. PMID: 15520826
37. Schipper HS, Prakken B, Kalkhoven E, Boes M. Adipose tissue-resident immune cells: key players in immunometabolism. Trends in Endocrinology & Metabolism. 2012; 23(8):407-15.
38. Chawla A, Nguyen KD, Goh YS. Macrophage-mediated inflammation in metabolic disease. Nature Reviews Immunology. 2011; 11(11):738-49. doi: 10.1038/nri3071 PMID: 21984069
39. Lumeng CN, Bodzin JL, Saltiel AR. Obesity induces a phenotypic switch in adipose tissue macrophage polarization. Journal of Clinical Investigation. 2007; 117(1):175. PMID: 17200717
40. Heilbronn LK, Campbell LV. Adipose tissue macrophages, low grade inflammation and insulin resistance in human obesity. Current pharmaceutical design. 2008; 14(12):1225-30. PMID: 18473870
41. Bourlier V, Zakaroff-Girard A, Miranville A, De Barros S, Maumus M, Sengenès C, et al. Remodeling phenotype of human subcutaneous adipose tissue macrophages. Circulation. 2008; 117(6):806-15. doi: 10.1161/CIRCULATIONAHA.107.724096 PMID: 18227385
42. Dalmas E, Clément K, Guerre-Millo M. Defining macrophage phenotype and function in adipose tissue. Trends in immunology. 2011; 32(7):307-14. doi: 10.1016/j.it.2011.04.008 PMID: 21616718
43. Bouhlel MA, Derudas B, Rigamonti E, Dièvart R, Brozek J, Haulon S, et al. PPARγ activation primes human monocytes into alternative M2 macrophages with anti-inflammatory properties. Cell metabolism. 2007; 6(2):137-43. PMID: 17681149
44. Odegaard JI, Ricardo-Gonzalez RR, Eagle AR, Vats D, Morel CR, Goforth MH, et al. Alternative M2 activation of Kupffer cells by PPAR5 ameliorates obesity-induced insulin resistance. Cell metabolism. 2008; 7(6):496-507. doi: 10.1016/j.cmet.2008.04.003 PMID: 18522831
45. Chawla A. Control of macrophage activation and function by PPARs. Circulation research. 2010; 106 (10):1559-69. doi: 10.1161/CIRCRESAHA.110.216523 PMID: 20508200
46. McTernan CL, McTernan PG, Harte AL, Levick P, Barnett A, Kumar S. Resistin, central obesity, and type 2 diabetes. The Lancet. 2002; 359(9300):46-7.
47. Lehrke M, Reilly MP, Millington SC, Iqbal N, Rader DJ, Lazar MA. An inflammatory cascade leading to hyperresistinemia in humans. PLoS medicine. 2004; 1(2):161.
48. SÁNCHEZ-POZO C, RODRIGUEZ-BAÑO J, DOMÍNGUEZ-CASTELLANO A, Muniain M, Goberna R, SÁNCHEZ-MARGALET V. Leptin stimulates the oxidative burst in control monocytes but attenuates the oxidative burst in monocytes from HIV-infected patients. Clinical & Experimental Immunology. 2003; 134(3):464-9.
49. Santos-Alvarez J, Goberna R, Sánchez-Margalet V. Human leptin stimulates proliferation and activation of human circulating monocytes. Cellular immunology. 1999; 194(1):6-11. PMID: 10357875
50. Hoffmann A, Kralisch S, Duhring S, Ebert T, Jeromin F, Kloting N, et al. Effects of leptin on macrophages in vivo. Atherosclerosis. 2014; 235(2):e194.